Related Experiment Video

Updated: Oct 26, 2025

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

14.6K

Immunosuppression in solid organ transplant recipients with Covid-19: More data, but still complicated

Madeleine R Heldman1, Olivia S Kates1, Cynthia E Fisher1

  • 1Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, USA.

Transplant Infectious Disease : an Official Journal of the Transplantation Society
|July 29, 2021
PubMed

Insights

Solid organ transplant recipients with COVID-19 had similar 28-day mortality compared to matched controls. Immunosuppression did not significantly increase mortality risk in this hospitalized patient group.

Area of Science:

  • Infectious Diseases
  • Transplant Medicine
  • Immunology

Background:

  • Investigating COVID-19 outcomes in solid organ transplant (SOT) recipients is crucial due to their immunocompromised status.
  • This matched cohort study compares hospitalized SOT recipients with non-transplant controls matched for comorbidities.

Discussion:

  • The study addresses the impact of immunosuppression on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection severity and mortality.
  • Findings suggest that while SOT recipients are vulnerable, their outcomes may be comparable to similarly ill non-transplant patients.

Key Insights:

  • Hospitalized SOT recipients and comorbidity-matched controls demonstrated similar 28-day mortality rates following COVID-19 diagnosis.
  • This indicates that immunosuppression, a hallmark of SOT, may not be an independent predictor of short-term mortality in this context.

Outlook:

  • Further research should explore long-term outcomes and the efficacy of COVID-19 treatments in SOT populations.
  • Understanding these dynamics can inform clinical management strategies and risk stratification for immunocompromised individuals.

Keywords:
Covid-19immunosuppressionsolid organ transplantation

More Related Videos

Investigating the Immunological Mechanisms Underlying Organ Transplant Rejection05:10

Investigating the Immunological Mechanisms Underlying Organ Transplant Rejection

Published on: August 20, 2007

6.2K
Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

16.3K

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
98
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
77.1K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
427
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.3K
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
112
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
102